Prophylactic antibiotics in first-trimester abortions: a clinical, controlled trial

Area of Science:

• Obstetrics and Gynecology
• Infectious Disease Prevention
• Pharmacology

Background:

• First-trimester abortions carry a risk of pelvic infectious complications.
• Identifying women at higher risk for these complications is crucial for targeted interventions.

Purpose of the Study:

• To evaluate the efficacy of prophylactic antibiotic therapy in preventing pelvic infections following induced first-trimester abortions.
• To determine if women with a history of pelvic inflammatory disease (PID) benefit specifically from prophylactic antibiotics.

Main Methods:

• A double-blind, placebo-controlled study involving 493 women undergoing first-trimester abortion.
• Treatment group received penicillin G and pivampicillin; control group received placebo.
• Pelvic infectious complications were monitored and compared between groups.

Main Results:

• Overall incidence of pelvic infections was lower in the antibiotic group (5.5%) compared to the placebo group (10.9%) (p=0.05).
• In women with a history of PID (N=105), infection rates were significantly lower with antibiotics (2.1%) versus placebo (22.4%) (p=0.006).

Conclusions:

• Prophylactic antibiotic therapy is effective in reducing infectious complications after first-trimester abortions.
• Antibiotic prophylaxis is particularly recommended for women with a history of pelvic inflammatory disease undergoing abortion.